Xuesong Wu

3.0k citations
90 papers · 2.2k indexed · h-index 29
Topics
Dermatology and Skin Diseases (15 papers)Psoriasis: Treatment and Pathogenesis (14 papers)Immunotherapy and Immune Responses (8 papers)
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Xuesong Wu

88 papers receiving 2.1k citations

Peers

Xuesong Wu
Comparison fields: 5 of 108
  • Molecular Biology 912
  • Immunology 787
  • Oncology 554
  • Dermatology 346
  • Cancer Research 328
Replace Wojciech Jóźwicki with:
Wojciech Jóźwicki Poland
Steve Carbajal United States
Xianying Xing United States
Nadine Martinet France
Ryuta Muromoto Japan
Baochun Zhang United States
Rainer Zenz Austria
Jun Sang Bae South Korea
Bruce Jaffee United States
Joëlle Simony-Lafontaine France
Xuesong Wu relative to Wojciech Jóźwicki Poland Wojciech Jóźwicki's profile →
Citations per field
00.5×
Wojciech Jóźwicki · 1×
Citations per year

Countries citing papers authored by Xuesong Wu

Since Specialization
Citations

This map shows the geographic impact of Xuesong Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuesong Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuesong Wu more than expected).

Fields of papers citing papers by Xuesong Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuesong Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuesong Wu. The network helps show where Xuesong Wu may publish in the future.

Co-authorship network of co-authors of Xuesong Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xuesong Wu. A scholar is included among the top collaborators of Xuesong Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuesong Wu. Xuesong Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 8
4 2
5 2
6 6
7 70
8 44
9 40
10 50
11 9
12 31
13 38
14 1
15 31
16 79
17 61
18 8
19 28
20 1

About Xuesong Wu

Xuesong Wu is a scholar working on Dermatology, Immunology and Immunology and Allergy, having authored 90 papers that have together received 2.2k indexed citations. Recurring topics across this work include Dermatology and Skin Diseases (15 papers), Psoriasis: Treatment and Pathogenesis (14 papers) and Immunotherapy and Immune Responses (8 papers). The work is most often cited by research in Dermatology (346 citations), Immunology (787 citations) and Cancer Research (328 citations). Xuesong Wu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Samuel Hwang, Sam T. Hwang, De‐Pei Liu, Chih‐Chuan Liang, Zhenrui Shi, Fangying Xu, Sebastian Yu, Yasutomo Imai, Maode Lai and Yu‐Jui Yvonne Wan. Their work appears in journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026